OphtiMedRx Ltd.

www.galilofek.com/ophtimedrx

High-Tech Company

Graduated from: OphtiMedRx

TECH VERTICALS

Life Sciences, MedTech, Pharmaceuticals

General Data

Sector	Biomed
Company Stage:	R&D
Established	2021
Number of Employees	5
Reg. Number:	abCDe

DESCRIPTION

OphtiMedRx is an ophthalmic drug development company, led by a team of physicians, scientists, and molecular biology experts. OphtiMedRx is developing a novel molecular therapy for dry Age-related Macular Degeneration (AMD), a common eye disease leading to blindness. This treatment protects retinal cells from senescence (cellular aging) and can halt progression of dry AMD. OphtiMedRx's cutting-edge therapy will prevent the loss of vision and independence and bring enormous benefit to patients.

TECHNOLOGY

Anti-senescence (cellular aging) agent for the treatment of dry AMD

	TARGET MARKETS
	Hospitals

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Katzrin, Israel

Address	C/O GO Fund and Innovation, Katzrin Industrial Area
POB	3608
City	Katzrin
Country	Israel
Zip	1290000

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Dr. Dana Rabinovich	CEO
Prof. Ayala Pollack	Co-Founder & Chief Medical Advisor

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	N\A
abC Defghij	Board Member	Founder, OphtiMedRx Ltd
abC Defghij	Board Member	CEO, Mor Research
abC Defghij	Board Member	Chairman & Co-owner, MIKAL GROUP
abC Defghij	Board Member	CEO, Galil Ofek Ventures